Key facts
- This page summarizes Jay Shepard's Form 4 filing for IRONWOOD PHARMACEUTICALS INC (IRWD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jun 2026, 16:47.
Jay Shepard - 16 Jun 2026 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)
- Reporting relationship
- Director
- Issuer ticker
- IRWD
- Reported as of
- 16 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2026, 16:47:05 UTC
- Prior SEC filing
- 01 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amir Vitale, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jay Shepard filed Form 4 for IRONWOOD PHARMACEUTICALS INC (IRWD) on 17 Jun 2026.
Change
- Previous filing in this sequence was filed on 01 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001587788
Primary reporting owner
Shepard Jay
- Relationship
- Director
- Address
- C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON
- Signature
- /s/ Amir Vitale, Attorney-in-Fact
- Signature date
- 17 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IRWD
transaction
Class A Common Stock
Award
- Transaction value
- Shares
- +63,481
- Change %
- +37%
- Price
- $0.000000*
- Shares after
- 235,036
- Date
- 16 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.